Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes
The current state of recombinant allergens for immunotherapy
Gabrielle Pauli
,
H-J Malling
Dermatology and Allergy
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The current state of recombinant allergens for immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Recombinant Allergen
100%
Allergen
66%
Clinical Efficacy
33%
Well-defined
33%
Allergic Rhinitis
33%
Allergic Asthma
33%
Allergen Extracts
33%
Pharmaceutical Quality
33%
Mass Unit
33%
Poor Quality
33%
Allergen Immunotherapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Allergen
100%
Recombinant Allergen
100%
Allergic Rhinitis
33%
Allergic Asthma
33%
Immunology and Microbiology
Immunotherapy
100%
Allergen
100%
Recombinant Allergen
100%
Allergic Asthma
33%
Allergic Rhinitis
33%